• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    MultiPlan Announces CEO Succession Plan

    1/4/24 8:00:00 AM ET
    $MPLN
    Business Services
    Consumer Discretionary
    Get the next $MPLN alert in real time by email

    Transition Aligned with Company's Growth Strategy and Next Phase of Product Innovation

    MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management solutions to the U.S. healthcare industry, announced that Travis Dalton will join the Company as President and CEO on March 1, 2024. He will succeed Dale White, who will remain active as Executive Chair of the Company, succeeding current Chair Mark Tabak.

    With over 20 years in healthcare technology leadership positions at Cerner Corporation and Oracle Health, Mr. Dalton is a proven leader with deep experience in leveraging technology, data, and analytics to enable better health outcomes and ensure client success in complex operating environments. He joined Cerner in 2001 and held senior executive roles across a number of enterprise and growth market areas. He was responsible for the launch and development of two key market business units which he grew to scale. He also drove large-scale technology engagements connecting market and product innovations to deliver client value. During his tenure at Cerner, the company grew revenue from $500 million in 2001 to $5.7 billion in 2021. Mr. Dalton was named general manager of Oracle Health when the acquisition of Cerner was completed in 2022.

    Mr. Dalton joins MultiPlan at the early stages of its Growth Plan engineered to propel the Company's competitive advantage through new product investment, building upon the value of MultiPlan's platform and customer relationships. The Company has already made significant progress advancing that plan since announcing it in February 2023, including establishing a new Data & Decision Science service line with the acquisition of Benefits Science Technologies and the addition of B2B healthcare payment services through a partnership with ECHO Health.

    "With our Growth Plan underway, now is the right time to bolster the leadership team, expand our operating capability, and supercharge our product development," said Mr. White. "I welcome Travis as my successor. He is a proven leader with experience driving and scaling product innovation, who is focused on delivering customer value, and has the exact capabilities to lead us through this exciting next chapter."

    As Executive Chair, Mr. White will work closely with Mr. Dalton to drive the Growth Plan forward, leveraging his extensive industry contacts and longstanding relationships with key customers. Mr. Tabak will remain on the Board as a director through the remainder of his term, which concludes in April, 2024.

    "I'm excited to join MultiPlan at this pivotal time as it transforms customer value with the addition of significant new capabilities to its industry leading technology platform," Mr. Dalton said. "Healthcare is too important to remain the same, and I believe MultiPlan has a vital role to play at the intersection of healthcare, data and information technology. I'm passionate about the potential for cutting edge products and enhanced data and analytics to solve the healthcare industry's most pressing business challenges. MultiPlan's platform, people, solutions and growth strategy are strongly positioned to deliver on that promise."

    "On behalf of the Board of Directors, I want to thank Dale for his invaluable contributions to MultiPlan and his willingness to remain active with key customers in driving the Growth Plan as Executive Chair," said Mark Tabak, Chair of the Board of MultiPlan. "No one has been more devoted to the Company's mission, its customers and its employees than Dale, and it has been a privilege to have partnered with him as we built this great company."

    Added Dale White, "In his 23 years leading and guiding the Company, Mark Tabak has seen us through unprecedented transformation, taking MultiPlan from a small, single product company to a market leader in healthcare affordability with a full suite of services for commercial, government and property/casualty health plans. I have worked closely with him since joining MultiPlan in 2004, and there is no better partner for driving growth. On behalf of our entire company, I extend our thanks and best wishes."

    About MultiPlan

    MultiPlan is committed to delivering affordability, efficiency, and fairness to the US healthcare system by helping healthcare payors manage the cost of care, improve their competitiveness and inspire positive change. Leveraging sophisticated technology, data analytics and a team rich with industry experience, MultiPlan interprets customers' needs and customizes innovative solutions that combine its payment and revenue integrity, network-based and analytics-based services. MultiPlan is a trusted partner to over 700 healthcare payors in the commercial health, government, and property and casualty markets. For more information, visit multiplan.com.

    Forward Looking Statements

    This press release contains forward-looking statements. These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms "believes," "estimates," "anticipates," "expects," "seeks," "projects," "forecasts," "intends," "plans," "may," "will" or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts, including the discussion in this press release of the expected leadership transitions and the anticipated impact thereof on the Company, as well as the Company's growth plan. The forward-looking statements are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995 and speak only as of the date they are made. Any forward-looking statements that we make herein are not guarantees of future performance and actual results may differ materially from those in such forward-looking statements as a result of various factors. Factors that may impact such forward-looking statements also include the factors discussed under "Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and our Quarterly Report on Form 10-Q for the quarter and nine months ended September 30, 2023; and other factors beyond our control. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The Company's periodic and other filings are accessible on the SEC's website at www.sec.gov. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240103384985/en/

    Get the next $MPLN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MPLN

    DatePrice TargetRatingAnalyst
    6/26/2024$2.00Neutral
    Piper Sandler
    12/13/2022$3.00 → $2.00Buy → Neutral
    Citigroup
    7/12/2022$6.50Neutral
    Goldman
    12/20/2021$9.00 → $7.00Buy
    Citigroup
    11/11/2021$7.00 → $6.00Equal-Weight
    Barclays
    10/4/2021$9.00Buy
    Citigroup
    8/20/2021$9.00Buy
    Tigress Financial
    More analyst ratings

    $MPLN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SVP, Chief Information Officer Kim Michael bought $249,588 worth of shares (40,000 units at $6.24), increasing direct ownership by 3% to 1,312,772 units (SEC Form 4)

      4 - MultiPlan Corp (0001793229) (Issuer)

      11/19/24 4:35:27 PM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • SVP, Corp. Affairs/Strategy Mintz William B. bought $104,359 worth of shares (278,165 units at $0.38), increasing direct ownership by 14% to 2,206,736 units (SEC Form 4)

      4 - MultiPlan Corp (0001793229) (Issuer)

      8/8/24 4:30:55 PM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • Pres., Chief Executive Officer Dalton Travis bought $185,000 worth of shares (500,000 units at $0.37), increasing direct ownership by 11% to 5,004,504 units (SEC Form 4)

      4 - MultiPlan Corp (0001793229) (Issuer)

      8/7/24 6:05:14 PM ET
      $MPLN
      Business Services
      Consumer Discretionary

    $MPLN
    Leadership Updates

    Live Leadership Updates

    See more

    $MPLN
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $MPLN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $MPLN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • MultiPlan Appoints Tiffani Misencik to Drive Strategic Growth

      Tiffani Misencik Named Chief Growth Officer in New Executive Leadership Role MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today announced a new addition to its executive leadership team to support the next phase of the Company's strategic growth. Tiffani Misencik has been appointed Chief Growth Officer. In this newly created role, Misencik will oversee MultiPlan's sales and revenue growth strategy across all market segments. She will lead the company's efforts in client acquisition, client management, an

      10/22/24 2:00:00 PM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • MultiPlan Makes Fortune's Best Workplaces in Health Care List for Second Year in a Row

      MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of technology and data-enabled cost management, payment, and revenue integrity solutions to the U.S. health care industry, is honored to announce it has been named in the 2024 Fortune Best Workplaces in Health Care™ List. based on its 2023-2024 Great Place to Work® Certification™ results. This is the second time MultiPlan has been named in the Best Workplaces in Health Care list. Earning a spot means that MultiPlan is one of the best companies to work for in the country. The Best Workplaces in Health Care list is based on analysis of survey responses from over 185,000 employees from Great Place To Work Cer

      9/12/24 8:30:00 AM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • MultiPlan Announces CFO Transition

      MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today its CFO transition plan and named Doug Garis as EVP and CFO, effective August 5, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731993142/en/Doug Garis named EVP and CFO of MultiPlan (Photo: Business Wire) Jim Head, who has served as EVP and CFO of MultiPlan since November 2021, will transition to a Strategic Advisor role to the Company through the end of the

      8/1/24 6:00:00 AM ET
      $DOOR
      $MPLN
      $ORCL
      $CERN
      Forest Products
      Basic Materials
      Business Services
      Consumer Discretionary
    • ClearNote Health's Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev's National PPO Networks

      Latest agreement expands access to the PHCS and MultiPlan Networks ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced an agreement with Claritev, Inc. ("Claritev") (NYSE:CTEV), previously MultiPlan, Inc. (NYSE:MPLN), a technology and data insights company focused on making healthcare more affordable, transparent, and fair for all. As part of the agreement, ClearNote Health's Avantect® Pancreatic Cancer Test will now be available to health plan members accessing Claritev's national PHCS and MultiPlan Networks. While early detection has vastly improved survival rates for many types of cancer, pancreatic cancer is often diagnos

      3/12/25 8:03:00 AM ET
      $CTEV
      $MPLN
      Business Services
      Consumer Discretionary
    • Claritev Reports Fourth Quarter and Full Year 2024 Results with Initial Guidance for Full Year 2025

      Q4 2024 Revenues of $232.1 million, Net Loss of $138.0 million and Adjusted EBITDA of $141.6 million Full Year 2024 Revenues of $930.6 million, Net Loss of $1,645.8 million and Adjusted EBITDA of $576.7 million Full Year 2025 Revenues guidance of (2)% to flat as compared to FY 2024 and FY 2025 Adjusted EBITDA % guidance of 62.5% to 63.5% Claritev Corporation ("Claritev" or the "Company") (NYSE:MPLN), formerly known as MultiPlan, a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the fourth quarter and full year ended December 31, 2024. Chairman, CEO and President Travis Dalt

      2/25/25 6:00:00 AM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • Claritev Provides Oracle Cloud HCM Customers with Actionable Insights for Healthcare Cost Optimization and Plan Design

      Claritev's Award-Winning Analytics Solution, BenInsights®, is Powered by Oracle Cloud and Now Available in the Oracle Cloud Marketplace Claritev Corporation ("Claritev" or the "Company") (NYSE:MPLN), formerly known as MultiPlan, a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, and an Oracle partner, announced today its analytics solution, BenInsights®, has achieved Integrated with Oracle Cloud Expertise and is now available in the Oracle Cloud Marketplace, offering added value to Oracle Cloud customers. The BenInsights platform enables visibility into benefit plan performance and compliance responsibilities for employers of

      2/21/25 8:00:00 AM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • Piper Sandler initiated coverage on MultiPlan with a new price target

      Piper Sandler initiated coverage of MultiPlan with a rating of Neutral and set a new price target of $2.00

      6/26/24 7:57:01 AM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • MultiPlan downgraded by Citigroup with a new price target

      Citigroup downgraded MultiPlan from Buy to Neutral and set a new price target of $2.00 from $3.00 previously

      12/13/22 9:12:38 AM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • Goldman initiated coverage on MultiPlan with a new price target

      Goldman initiated coverage of MultiPlan with a rating of Neutral and set a new price target of $6.50

      7/12/22 7:32:35 AM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by MultiPlan Corporation

      SC 13G/A - MultiPlan Corp (0001793229) (Subject)

      11/12/24 4:00:27 PM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by MultiPlan Corporation

      SC 13G/A - MultiPlan Corp (0001793229) (Subject)

      11/4/24 3:13:44 PM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by MultiPlan Corporation

      SC 13G/A - MultiPlan Corp (0001793229) (Subject)

      11/4/24 1:43:06 PM ET
      $MPLN
      Business Services
      Consumer Discretionary

    $MPLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: SEC Form 4 filed by SVP, Chief Information Officer Kim Michael

      4/A - MultiPlan Corp (0001793229) (Issuer)

      12/13/24 4:28:52 PM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • SVP, Chief Information Officer Kim Michael bought $249,588 worth of shares (40,000 units at $6.24), increasing direct ownership by 3% to 1,312,772 units (SEC Form 4)

      4 - MultiPlan Corp (0001793229) (Issuer)

      11/19/24 4:35:27 PM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • SVP, Chief Growth Officer Misencik Tiffani was granted 95,328 shares (SEC Form 4)

      4 - MultiPlan Corp (0001793229) (Issuer)

      10/16/24 5:01:01 PM ET
      $MPLN
      Business Services
      Consumer Discretionary

    $MPLN
    Financials

    Live finance-specific insights

    See more
    • Claritev Reports Fourth Quarter and Full Year 2024 Results with Initial Guidance for Full Year 2025

      Q4 2024 Revenues of $232.1 million, Net Loss of $138.0 million and Adjusted EBITDA of $141.6 million Full Year 2024 Revenues of $930.6 million, Net Loss of $1,645.8 million and Adjusted EBITDA of $576.7 million Full Year 2025 Revenues guidance of (2)% to flat as compared to FY 2024 and FY 2025 Adjusted EBITDA % guidance of 62.5% to 63.5% Claritev Corporation ("Claritev" or the "Company") (NYSE:MPLN), formerly known as MultiPlan, a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the fourth quarter and full year ended December 31, 2024. Chairman, CEO and President Travis Dalt

      2/25/25 6:00:00 AM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • MultiPlan Corporation Announces Fourth Quarter and Full Year 2024 Earnings Conference Call

      MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of technology and data solutions that improve affordability, quality and transparency in healthcare, announced today that it will release its fourth quarter and full year 2024 financial results on Tuesday, February 25, 2025, and hold its conference call that morning at 8:00 am Eastern Time. To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique pin. Pre-registration may be completed at any time up to and following the call start time. To pre-register, go to: https://www.netroadsho

      1/28/25 8:30:00 AM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • MultiPlan Reports Third Quarter 2024 Results and Updates 2024 Guidance

      – Q3 2024 Revenues of $230.5 million, Net Loss of $391.5 million (including a $361.6 million impairment of goodwill and indefinite-lived intangibles), and Adjusted EBITDA of $141.6 million – Identified potential medical cost savings of approximately $6.4 billion in Q3 2024, up 10% from Q3 2023 and up 3% from Q2 2024 MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today reported financial results for the third quarter ended September 30, 2024 and updated its full-year 2024 guidance. CEO Travis Dalton said,

      11/5/24 6:00:00 AM ET
      $MPLN
      Business Services
      Consumer Discretionary

    $MPLN
    SEC Filings

    See more
    • SEC Form 10-K filed by MultiPlan Corporation

      10-K - Claritev Corp (0001793229) (Filer)

      2/26/25 7:50:06 AM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • MultiPlan Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Claritev Corp (0001793229) (Filer)

      2/25/25 6:21:17 AM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • MultiPlan Corporation filed SEC Form 8-K: Other Events

      8-K - Claritev Corp (0001793229) (Filer)

      2/24/25 8:02:11 AM ET
      $MPLN
      Business Services
      Consumer Discretionary